Skip to main content
. 2019 Aug 27;293(1):223–231. doi: 10.1148/radiol.2019190199

Figure 2:

Figure 2:

Graph shows Kaplan-Meier curves for overall survival by group. Group A includes treatment-naïve participants with no prior liver-directed and systemic therapies and group B includes participants who experienced hepatic tumor progression following immunoembolization.